-
1
-
-
0014138538
-
Carcinoma of the prostate: Treatment comparisons
-
Veterans Administration Cooperative Urological Research Group. Carcinoma of the prostate: treatment comparisons. J Urol 1967;98:516-22.
-
(1967)
J Urol
, vol.98
, pp. 516-522
-
-
-
2
-
-
0022469720
-
Orchidectomy versus oestrogen tor prostatic cancer: Cardiovascular effects
-
Henriksson P, Edhag O. Orchidectomy versus oestrogen tor prostatic cancer: cardiovascular effects. Br Med J 1986;93:413-5.
-
(1986)
Br Med J
, vol.93
, pp. 413-415
-
-
Henriksson, P.1
Edhag, O.2
-
3
-
-
0026458371
-
Hormone therapy to prevent disease and prolong life in postmenopausal women
-
Grady D, Rubin SM, Petitti DB et al. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992;117:1016-37.
-
(1992)
Ann Intern Med
, vol.117
, pp. 1016-1037
-
-
Grady, D.1
Rubin, S.M.2
Petitti, D.B.3
-
4
-
-
0018150863
-
Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogen and progestins
-
Bradly DD, Wingerd J, Petitti DB, Krauss RM, Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogen and progestins. N Engl J Med 1978;299:17-20.
-
(1978)
N Engl J Med
, vol.299
, pp. 17-20
-
-
Bradly, D.D.1
Wingerd, J.2
Petitti, D.B.3
Krauss, R.M.4
Ramcharan, S.5
-
5
-
-
0018749716
-
Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use
-
Wallace RB, Hoover J, Barrett-Conner E et al. Altered plasma lipid and lipoprotein levels associated with oral contraceptive and oestrogen use. Lancet 1979;2:111-15.
-
(1979)
Lancet
, vol.2
, pp. 111-115
-
-
Wallace, R.B.1
Hoover, J.2
Barrett-Conner, E.3
-
6
-
-
0024418329
-
Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma
-
Eriksson M, Berglund L, Rudling M, Henriksson P, Angelin B. Effects of estrogen on low density lipoprotein metabolism in males. Short-term and long-term studies during hormonal treatment of prostatic carcinoma. J Clin Invest 1989;84:802-10.
-
(1989)
J Clin Invest
, vol.84
, pp. 802-810
-
-
Eriksson, M.1
Berglund, L.2
Rudling, M.3
Henriksson, P.4
Angelin, B.5
-
7
-
-
0026628106
-
Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma
-
Henriksson P, Angelin B, Berglund L. Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest 1989;89:1166-77.
-
(1989)
J Clin Invest
, vol.89
, pp. 1166-1177
-
-
Henriksson, P.1
Angelin, B.2
Berglund, L.3
-
8
-
-
0026035002
-
Plasma Lp (a) concentration after oestrogen and progestagen in postmenopausal women
-
M Soma, R Fumagalli, R Paoletti et al. Plasma Lp (a) concentration after oestrogen and progestagen in postmenopausal women. Lancet 1991;337:612.
-
(1991)
Lancet
, vol.337
, pp. 612
-
-
Soma, M.1
Fumagalli, R.2
Paoletti, R.3
-
9
-
-
0024263403
-
Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate
-
Henriksson P, Eriksson A, Stege R et al. Cardiovascular follow-up of patients with prostatic cancer treated with single-drug polyestradiol phosphate. Prostate 1988;13:257-61.
-
(1988)
Prostate
, vol.13
, pp. 257-261
-
-
Henriksson, P.1
Eriksson, A.2
Stege, R.3
-
10
-
-
0022913802
-
Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy
-
Henriksson P, Blombäck M, Bratt G, Edhag O, Eriksson A. Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy. Thromb Res 1986;44:783-91.
-
(1986)
Thromb Res
, vol.44
, pp. 783-791
-
-
Henriksson, P.1
Blombäck, M.2
Bratt, G.3
Edhag, O.4
Eriksson, A.5
-
11
-
-
0024446399
-
Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer
-
Henriksson P, Blombäck M, Bratt G. Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer. Med Oncol Tumour Pharmacother 1989;6:219-25.
-
(1989)
Med Oncol Tumour Pharmacother
, vol.6
, pp. 219-225
-
-
Henriksson, P.1
Blombäck, M.2
Bratt, G.3
-
12
-
-
0019433760
-
The effects of orchidectomy, estrogen and cyproterone acetate on the antithrombin III concentrations in carcinoma of the prostate
-
Varenhorst E, Wallentin L, Risberg B. The effects of orchidectomy, estrogen and cyproterone acetate on the antithrombin III concentrations in carcinoma of the prostate. Urol Res 1981;9:25-8.
-
(1981)
Urol Res
, vol.9
, pp. 25-28
-
-
Varenhorst, E.1
Wallentin, L.2
Risberg, B.3
-
13
-
-
0022469720
-
Effects of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma
-
Henriksson P, Blombäck M, Eriksson A, Stege R, Carlström K. Effects of parenteral oestrogen on the coagulation system in patients with prostatic carcinoma. Br Med J 1986;293:413-5.
-
(1986)
Br Med J
, vol.293
, pp. 413-415
-
-
Henriksson, P.1
Blombäck, M.2
Eriksson, A.3
Stege, R.4
Carlström, K.5
-
14
-
-
0021266160
-
1α and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs
-
1α and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. Prostagland 1984;28:139-54.
-
(1984)
Prostagland
, vol.28
, pp. 139-154
-
-
Vesterqvist, O.1
Green, K.2
-
16
-
-
0024800706
-
Drug interactions with the in vivo synthesis of thromboxane and prostacyclin
-
Gréen K, Vesterqvist O. Drug interactions with the in vivo synthesis of thromboxane and prostacyclin. Drug Metabol Drug Interact 1989;7:321-51.
-
(1989)
Drug Metabol Drug Interact
, vol.7
, pp. 321-351
-
-
Gréen, K.1
Vesterqvist, O.2
-
17
-
-
0025100872
-
Experimental atherosclerosis: Effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation
-
Fogelberg M, Vesterqvist O, Diczfalusy U, Henriksson P. Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation. Eur J Clin Invest 1990;20:105-10.
-
(1990)
Eur J Clin Invest
, vol.20
, pp. 105-110
-
-
Fogelberg, M.1
Vesterqvist, O.2
Diczfalusy, U.3
Henriksson, P.4
-
18
-
-
0027991286
-
Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets
-
Matsuda K, Ruff A, Morinelli TA, Mathur RS, Halushka PV. Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol 1994;267:H887-93.
-
(1994)
Am J Physiol
, vol.267
-
-
Matsuda, K.1
Ruff, A.2
Morinelli, T.A.3
Mathur, R.S.4
Halushka, P.V.5
|